Search

Author/Creator Mou, Haibo

1. Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988–2013). (2nd April 2018)

Authors:
Mou, Haibo; Liao, Qin; Hou, Xuehua; Chen, Te; Zhu, Yuping
Journal:
International journal of radiation biology
Issue:
Volume 94:Number 5(2018)
Page Start:
495
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response. Issue 4 (12th August 2020)

Authors:
Li, Jingjing; Wei, Qing; Wu, Xiaoying; Sima, Jun; Xu, Qi; Wu, Mengmeng; Wang, Fufeng; Mou, Haibo; Hu, Hanguang; Zhao, Jianguo; Li, Da; Hu, Jinlin; Zhang, Lingnan; Zhu, Xiu; Chen, Lei; Luo, Cong; Yan, Junrong; He, Jiachen; Ma, Yutong; Shao, Yang
Journal:
Clinical and translational medicine
Issue:
Volume 10:Issue 4(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Programmed cell death‐ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristics. Issue 9 (10th March 2021)

Authors:
Mou, Haibo; Yang, Qiu‐an; Yu, Lanfang; Wang, Ting; Liu, Kui; Shen, Rong; Pan, Xuedong; Dai, Yi; Wan, Qing; Zhou, Fangling; Qian, Lili; Chen, Donglin; Yau, Thomas; Dong, Xiaowei; Wang, Xuemei; Wang, Shuang
Journal:
Journal of gastroenterology and hepatology
Issue:
Volume 36:Issue 9(2021)
Page Start:
2601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗